Causes of death and characteristics of decedents with viral hepatitis, United States, 2010

Clinical Infectious Diseases

Volumn 58, Issue 1, 2014, Pages 40-49

  Ly, Kathleen N ^a   Xing, Jian ^a   Klevens, R Monina ^a   Jiles, Ruth B ^a   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

causes of death; death certificates; mortality; viral hepatitis

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BILE DUCT CANCER; CAUSE OF DEATH; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; KIDNEY FAILURE; LIVER CANCER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEPTICEMIA; UNITED STATES; YOUNG ADULT;

CAUSES OF DEATH; DEATH CERTIFICATES; MORTALITY; VIRAL HEPATITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMANS; INFANT; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84891364951     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit642     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention. Viral hepatitis surveillance-United States, 2009. 2011. Available at: http://www.cdc.gov/ hepatitis/Statistics/2009Surveillance/index.htm. Accessed 20 December 2011.
2. Centers for Disease Control and Prevention. CDC/CSTE Case Definitions. Available at: http://wwwn.cdc.gov/NNDSS/script/casedefDefault. aspx. Accessed 5 September 2013.
3. Vogt T, Wise M, Bell B, Finelli L. Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis 2008; 197:1282-8.
4. Ly K, Xing J, Klevens R, Jiles R, Ward J, Holmberg S. The growing burden of mortality from viral hepatitis in the United States, 1999-2007. Ann Intern Med 2012; 156:271-8.
5. Institute of Medicine. Colvin HM, Mitchell AE, eds. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: The National Academies Press, 2010.
6. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010; 202:192-201.
7. Armstrong G, Wasley A, Simard E, McQuillan G, Kuhnert W, Alter M. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-14.
8. Volk M, Tocco R, Saini S, Lok A. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology 2009; 50:1750-5.
9. Bell B, Manos M, Zaman A, Terrault N, Thomas A. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 2008; 103:2727-36.
10. Lee M, Yang H, Lu S, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis 2012; 206:469-77.
11. El-Kamary S, Jhaveri R, Shardell M. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general U.S. population. Clin Infect Dis 2011; 53:150-7.
12. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large communitybased linkage study. Lancet 2006; 368:938-45.
13. Moorman A, Gordon S, Rupp L, et al. Baseline characteristics and mortality among people in care for chronic viral hepatitis: the Chronic Hepatitis Cohort Study. Clin Infect Dis 2013; 56:40-50.
14. National Center for Health Statistics. Mortality multiple cause-of-death public use record for 2010, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Available at: http://www.cdc.gov/nchs/nvss/mortality-methods. htm. Accessed 27May 2013.
15. World Health Organization. International Classification of Diseases. 10th Revision. Geneva, Switzerland: WHO, 1998. Available at: http://apps.who.int/ classifications/icd10/browse/2010/en. Accessed 14 June 2013.
16. National Center for Health Statistics. Public use data set documentation-mortality for ICD-10. 1999. Available at: http://ftp.cdc.gov/pub/ health-statistics/nchs/Dataset-Documentation/mortality/Mort99doc. pdf. Accessed 15 June 2010.
17. Institute for Social Research, University of Michigan. Coded causes of death. Available at: http://simba.isr.umich.edu/restricted/docs/Mortal ity/codedcauses-readfirst.pdf. Accessed 5 September 2013.
18. Wise M, Bialek S, Finelli L, Beth B, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 2008; 47:1128-35.
19. National Center for Health Statistics. Instructions for classifying the underlying cause of death, ICD-10, 2010. Available at: http://www.cdc. gov/nchs/data/dvs/2A-2010acc.pdf. Accessed 4 April 2011.
20. Thomas A, Zaman A, Bell B. Deaths from chronic liver disease and viral hepatitis, Multnomah County, Oregon, 2000. J Clin Gastroenterol 2007; 41:859-62.
21. National Center for Health Statistics. Vintage 2010 bridged-race postcensal population estimates. Available at: http://www.cdc.gov/nchs/nvss/ bridged-race/data-documentation.htm#vintage2010. Accessed 13 October 2012.
22. Klein R, Schoenborn C. Age adjustment using the 2000 projected U.S. population. Healthy People 2010. Stat Notes 2001; 20:1-10.
23. Miniño A, Murphy S, Xu J, Kochanek K. Deaths: final data for 2008. Natl Vital Stat Rep 2011; 59:1-157.
24. Agency for Healthcare Research and Quality. Clinical classifications software (CCS) for ICD-10. Available at: http://www.hcup-us.ahrq.gov/ toolssoftware/icd-10/ccs-icd-10.jsp. Accessed 15 March 2011.
25. Murphy S, Xu J, Kochanek K. Deaths: preliminary data for 2010. Natl Vital Stat Rep 2012; 60:1-68.
26. Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012; 61(RR04): 1-18.
27. Rein D, Smith B, Wittenborn J, et al. The cost-effectiveness of birthcohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med 2012; 156:263-70.
28. Backus L, Boothroyd D, Phillips B, Belperio P, Halloran J, Mole L. A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol 2011; 9:509-16.
29. van der Meer A, Veldt B, Feld J, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308:2584-93.
30. Schiff E. Prevention of mortality from hepatitis B and hepatitis C. Lancet 2006; 368:896-7.
31. El-Serag H, Mason A. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745-50.
32. El-Serag H. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127:s27-34.
33. Centers for Medicare & Medicaid Services. Overview: Physician Quality Reporting Initiative. Available at: www.cms.hhs.gov/pqri/. Accessed 14 June 2010.
34. Kanwal F, Schnitzler M, Bacon B, Hoang T, Buchanan P, Asch S. Quality of care in patients with chronic hepatitis C virus infection. Ann Intern Med 2010; 153:231-9.
35. Wexelman BA, Eden E, Rose KM. Survey of New York City resident physicians on cause-of-death reporting, 2010. Prev Chronic Dis 2013; 10:1-12.
36. Sehdev A, Hutchins G. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med 2001; 161: 277-84.
37. Manos M, LeydenW, Murphy R, Terrault N, Bell B. Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment. Hepatology 2008; 47:1150-7.